Quick Answer
Kairos Pharma, LTD. reported Total Assets of $6.54 million for fiscal year 2025.
Kairos Pharma, LTD. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $6.54M | +13.4% |
| 2024 | $5.77M | +497.7% |
| 2023 | $965.0K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $8.07M | +61.2% | +20.9% |
| June 30, 2025 | $6.67M | — | -15.9% |
| March 31, 2025 | $7.94M | — | +37.6% |
| December 31, 2024 | $5.77M | +497.7% | +15.3% |
| September 30, 2024 | $5.00M | — | +418.5% |
| December 31, 2023 | $965.0K | — | — |
- Kairos Pharma, LTD. showed an increase of +13.4% in Total Assets compared to the prior fiscal year.
- Over the 2023–2025 period, Kairos Pharma, LTD.’s total assets has grown by 577.7% (from $965.0 thousand to $6.54 million).
- The most recent figure is from Kairos Pharma, LTD.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: